LGBT Cancer Project

Therapeutic Areas: Oncology

Mesothelioma Clinical Trials

A listing of Mesothelioma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35249

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

California

UPDATED

San Francisco California 94115

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

Colorado

UPDATED

Colorado Springs Colorado 80907

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

Illinois

UPDATED

Chicago Illinois 60637

A clinical research study of BAY 94-9343, Pemetrexed and Cisplatin for the treatment of Medical Oncology, Solid Tumors

Maryland

UPDATED

Bethesda Maryland 20892

A clinical research study of BAY 94-9343, Pemetrexed and Cisplatin for the treatment of Medical Oncology, Solid Tumors

Michigan

UPDATED

Detroit Michigan 48202

A clinical research study of BAY 94-9343, Pemetrexed and Cisplatin for the treatment of Medical Oncology, Solid Tumors

Nevada

UPDATED

Henderson Nevada 89052

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

South Carolina

UPDATED

Charleston South Carolina 29425

A clinical research study of BAY 94-9343, Pemetrexed and Cisplatin for the treatment of Medical Oncology, Solid Tumors

UPDATED

Greenville South Carolina 29615

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

Texas

UPDATED

Houston Texas 77030

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

McAllen Texas 78503

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

San Antonio Texas 78217

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

Washington

UPDATED

Spokane Valley Washington 99216

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

Argentina

UPDATED

Ciudad Autonoma Buenos Aires X5004FHP

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Ciudad Autónoma de Bs As C1426ANZ

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Ciudad Autónoma de Bs As C1180AAX

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

Australia

UPDATED

Box Hill Victoria 3128

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Chermside Queensland 4032

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Frankston Victoria 3199

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Heidelberg Victoria 3084

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Nedlands Western Australia 6009

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Perth Western Australia 6000

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

South Brisbane Queensland 4101

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

St. Leonards New South Wales 2065

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Waratah New South Wales 2298

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Wodonga Victoria 3690

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

Austria

UPDATED

Leoben 8700

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Wels 4600

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

Belgium

UPDATED

Brussels 1200

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Edegem 2650

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Ghent 9000

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Leuven 3000

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Mechelen 2800

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

Canada

UPDATED

Halifax Nova Scotia B3H 1V7

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Quebec GLV 4G5

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Sudbury Ontario P3E 5J1

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Toronto Ontario M5G 2M9

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

Chile

UPDATED

Recoleta 8420383

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Vitacura 7630372

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

Croatia

UPDATED

Osijek 31000

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Zagreb 10000

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

Czechia

UPDATED

Brno 625 00

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Olomouc 779 00

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

Egypt

UPDATED

Alexandria 21131

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Alexandria 21648

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Cairo 11796

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Cairo 12655

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

France

UPDATED

Bordeaux 33000

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Brest 29609

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)

UPDATED

Caen 14033

A Phase 2 clinical study for patients with Mesothelioma (BIBF 1120)